Weekly shot shows promise for blood sugar and weight control in type 1 diabetes
NCT ID NCT05537233
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tested a once-weekly medicine called semaglutide in 115 adults with type 1 diabetes and obesity who already use an automated insulin pump. The goal was to see if adding semaglutide helps improve blood sugar control and reduce weight. Participants received either semaglutide or a placebo for 26 weeks, and researchers measured changes in blood sugar levels and body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barbara Davis Center for Diabetes
Aurora, Colorado, 80045, United States
-
Harold Schnitzer Diabetes Health Center
Portland, Oregon, 97239, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
Iowa Diabetes Research Center
West Des Moines, Iowa, 50265, United States
Conditions
Explore the condition pages connected to this study.